跳至主要内容
临床试验/JPRN-UMIN000039449
JPRN-UMIN000039449已完成未知

Multicenter prospective study on oral management for preventing medication-related osteonecrosis of the jaw in patients receiving high-dose antiresorptive agent - Prevention of medication-related osteonecrosis of the jaw in patients receiving high-dose antiresorptive agent

agasaki University Graduate School of Biomedical Sciences0 个研究点目标入组 300 人开始时间: 2020年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • edentrous patient

研究者

发起方
agasaki University Graduate School of Biomedical Sciences

相似试验

已完成
不适用
Multicenter study of oral management for prevention of surgical site infection in oral cancer surgeryOral cancer
JPRN-UMIN000018318Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences150
招募中
Unknown
An observational study on oral function management of oral frail items and GLIM criteria for diagnosis of malnutrition in head and neck cancer patientshead and neck cancer68006258
JPRN-jRCT1042230008Yamada Yoichi120
进行中(未招募)
1 期
A clinical study of oral LDK378 in adult patients with ALK-activated non-small cell lung cancer previously treated with chemotherapy and crizotinibon-small cell lung cancerMedDRA version: 16.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-003432-24-DEovartis Pharma Services AG137
进行中(未招募)
1 期
A clinical study of oral LDK378 in adult patients with ALK-activated non-small cell lung cancer and who have not been previously treated with crizotinibon-small cell lung cancerMedDRA version: 18.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-003474-36-SEovartis Pharma Services AG105
进行中(未招募)
1 期
A clinical study of oral LDK378 in adult patients with ALK-activated non-small cell lung cancer and who have not been previously treated with crizotinibon-small cell lung cancerMedDRA version: 14.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-003474-36-DEovartis Pharma Services AG105